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ABSTRACT 
Aim: Peri-operative hyperglycaemia is associated with an increased incidence of 
adverse outcomes. Communication between primary and secondary care is 
paramount to minimise these harms. National guidance in the UK recommends that 
the glycated haemoglobin (HbA1c) should be measured within 3 months prior to 
surgery and that the concentration should be less that 69mmol/mol (8.5%). In 
addition, national guidance outlines the minimum dataset that should be included in 
any letter at the time of referral to the surgeons. Currently it is unclear how well this 
process is being carried out. This study investigated the quality of information being 
handed over during the referral from primary care to surgical outpatients within the 
East of England. 
Methods: Primary care referrals to nine different NHS hospital Trusts were gathered 
over a 1 week period. All age groups were included from 11 different surgical 
specialties. Referral letters were analysed using a standardised data collection tool 
based on the national guidelines. 
Results: 1,919 referrals were received, of whom 169 (8.8%) had previously 
diagnosed diabetes mellitus (DM). However, of these 38 made no mention of DM in 
the referral letter but were on glucose lowering agents. Only 13 (7·7%) referrals for 
patients with DM contained a recent HbA1c, and 20 (11·8%) contained no 
documentation of glucose lowering medication. 
Conclusion: This study has shown that the quality of referral letters to surgical 
specialties for patients with DM in the East of England remain inadequate. There is a 
clear need for improving the quality of clinical data contained within referral letters 
from primary care. In addition, we have shown that the rate of referral for surgery for 
people with diabetes is almost 50% higher than the background population with 
diabetes.  
  
 
What’s known? 
Previous work has shown that, in the hospital setting, effective communication 
between the healthcare professionals; and between the healthcare professionals and 
the people with diabetes helps to improve outcomes.  
 
There are UK national guidelines on the management of adult patients with diabetes 
undergoing surgery. These include a recommended amount of information that 
should be passed from primary care to the surgeons at the time of referral. No work 
has been done looking at the quality of this communication 
 
What’s new?  
Our data show that the quality of referral letters could be improved with appropriate 
clinical information, to facilitate better clinical care, and that a lot of information that 
should be in the letter (including that the patient has diabetes) is not included. Thus, 
at the very first stage of the patients’ surgical journey there is room for improvement 
in the communication between primary and secondary care.  
 
In addition, we have shown that the rate of referral for surgery for people with 
diabetes is almost 50% higher than the background population with diabetes.   
  
INTRODUCTION 
Diabetes Mellitus (DM) is the most commonly occurring metabolic disorder in the 
United Kingdom (UK). In 2013, data suggested that the prevalence of patients with 
diagnosed DM in England amongst all age groups was 5.9%, a figure that had risen 
31% since 2009 [1]. In addition, it has been estimated that DM accounts for 10% of 
the entire budget of the UK National Health Service [2]. The 2015 National Diabetes 
Inpatient Audit (NaDIA) showed that 16.8% of all UK inpatient hospital beds were 
occupied by someone with diabetes, a relative increase of 15% since 2010 [3]. This 
is not to say that they were in hospital because of their diabetes, but happened to 
have it in addition to their primary underlying diagnosis – no matter what the 
speciality. However, surgical patients with DM have increased peri-operative 
morbidity, longer hospital length of stay and greater use of healthcare resources 
[4,5,6,7,8]. 
 
The process of managing a patient with DM undergoing surgery can be subdivided, 
following the patient journey. This journey starts with a primary care referral to the 
surgeon. The next step is the surgical outpatient appointment, and once the decision 
has been made that an elective procedure is required, the patient is often seen in a 
pre-operative assessment clinic. Soon afterwards, the patient is admitted to hospital 
to have their procedure when they are in the operating theatre, the recovery room 
and possibly on the wards. After their post-operative recovery, they are discharged 
home [9].  
 
Previous work has shown that standards of in-hospital care for patients with DM 
during their peri-operative journey remain suboptimal and that there is room for 
substantial improvement [10].  To try and improve things, there are national 
  
recommendations for the minimum data set that should be included in the primary 
care referral for a patient with DM who is being considered for surgery. These are 
listed in Table 1 [9]. However, to date there are no data to assess whether part of the 
suboptimal care could be due to a lack of information passed from primary to 
secondary care.    
 
The present study was aimed at the first step in this process, to assess the quality of 
information contained in referral letters from primary care to surgical outpatients. 
 
MATERIALS AND METHODS 
We collected data on every primary care surgical referral sent to nine National Health 
Service Trusts in the East of England between 28th July 2014 and 3rd August 2014. 
These hospitals are listed in Table 2. Data were collected using a standardised form 
(Figure 1). This was designed to reflect whether the specified minimum information 
was provided according to the UK national guideline on the management of adults 
with DM undergoing surgery and elective procedures [9]. All general surgical 
subspecialties (gastrointestinal, vascular, endocrine, breast) as well as trauma and 
orthopaedics, obstetrics and gynaecology, ear, nose and throat (ENT), plastic 
surgery, neurosurgery, paediatric and maxillofacial surgery were included. All GP 
referral letters of patients with previously diagnosed DM or treated with glucose 
lowering agents were identified.  
 
RESULTS 
Across the nine centres that participated in this study, data were collected for 1,919 
primary care referrals to surgery (Table 2). They included 1,053 females, 851 males 
  
and 15 patients with gender not documented. The median age was 53 years (range 6 
weeks to 98 years).  
 
The number of referrals received for each surgical specialty, including the number of 
patients with DM, is shown in Table 3. The majority of referrals were to trauma and 
orthopaedics, followed by general surgery and ENT. The highest proportion of 
patients with DM were referred to the vascular surgeons, reflecting the increased 
cardiovascular disease burden in the population with DM. 
 
One hundred and sixty nine referrals (8.8% of all referrals) were for patients with DM. 
As can be seen in Table 4, 117 (69.2%) were documented as having type 2 DM, 24 
(14.2%) were documented as having type 1 DM, and in 38 (22.5%) there was no 
documentation of the type of DM in the referral letter but were on glucose lowering 
agents. In addition, there were several key biochemical and physical examination 
findings that were not included in the referral letter, including almost half (49.7%) 
containing no documentation of DM related co-morbidities such as pre-existing 
hypertension, ischemic heart disease, neuropathy, foot disease or renal disease. 
Furthermore, in 11.8% of referrals no documentation of oral hypoglycaemic or 
insulin-based medication was provided. 
 
DISCUSSION 
This study has shown that the quality of referral letters from primary care to all 
surgical specialties for people with DM across the East of England could be improved 
with appropriate clinical information, to facilitate better clinical care. Most letters did 
not contain the information recommended by the UK national guideline on the 
management of adults with DM undergoing surgery and elective procedures [9].  We 
  
have also shown that the prevalence of DM amongst patients referred for elective 
surgery was almost 50% higher than the prevalence in the general UK population 
(8·8% vs 5·9%).  
 
The many stages of the patient journey from primary care referral to discharge home 
after an operation are fraught with difficulties for the patients with long-term 
conditions such as diabetes. There are many studies that demonstrate the 
association between poor peri-operative glycaemic control and adverse outcomes 
after all forms of surgery in patients with DM [11,12,13,14,15,16]. What is currently 
lacking however, is the data to show that intervention is associated with a reduction 
in harms [17]. However, the premise is that the achievement of good glucose control 
is likely to be associated with better outcomes. Key to achieving this is appropriate, 
timely and accurate communication between the relevant parties at each stage of the 
journey. Recent work has been done looking at parts of this journey within the 
hospital, in particular looking at developing a more patient centred approach to care 
[10]. This was because it was felt that this approach would contribute to a more 
positive patient experience, as well as delivering higher-quality inpatient DM care 
[18,19,10]. Hommel et al showed that the lack of appropriate handover of clinically 
important information related to DM was not limited to primary care, and that other 
parts of the patient journey also required improvement to increase perioperative 
safety [10]. However, this work was done looking at communication within the 
hospital, but none has been done looking at the first stage in the patient journey, the 
referral from primary care to the surgeons.  
 
Our data showed that in over 20% of cases, people with DM (identified by the 
medications they were taking), had no mention of the condition in their referral letter. 
  
The use of the electronic referral letter, with the past history and current drug list 
automatically generated should help to reduce this lack of data, but currently is not 
universally used. Anaesthetists and surgeons are aware that this information 
materially affects pre-operative planning of elective surgery, e.g. placing a person 
with diabetes at the start of an operating list to minimise their starvation time, and 
minimises the risk of inpatient management errors [20]. With the extensive data now 
showing that peri-operative hyperglycaemia is associated with harm, and that the 
awareness that someone has diabetes prior to their procedure helps to minimise any 
potential harms, HbA1c should be part of this standard information [21]. Ideally all of 
this information should be transferred at the time of referral and not left to be 
collected in the few days prior to the operation at the time of the pre-operative 
assessment clinic. This also dovetails with the principles of enhanced recovery 
programmes in surgery, which aim to optimise pre-operative health prior to surgery, 
thereby minimising hospital length of stay [22]. In the current study only 31.4% of the 
referred patients with DM had a recent blood pressure reading recorded in the 
referral letter, 27% had a recent BMI, and only 7.7% had a documented recent 
HbA1c reading (i.e. checked within the 3 months prior to referral). Recently published 
guidelines by NICE in the UK state that “people with diabetes who are being referred 
for surgical consultation from primary care should have their most recent HbA1c test 
results included in their referral information”, also that “if the patient has not been 
tested in the last 3 months then HbA1c testing should be offered” [21]. 
 
Previous work has shown that people with diabetes were already being 
inappropriately refused day case surgery [23,24]. But it is not just poor glycaemic 
control that leads to last minute cancellations of elective surgery. A recent paper 
  
highlighted the importance of pre-operative medical optimisation for hypertension to 
avoid such cancellations [25].  
 
Information on hypertension, other DM related co-morbidities and medical 
management of glycaemic control was also lacking in many referral letters. Almost 
half of all referrals had no documentation DM related co-morbidities such as 
hypertension, ischemic heart disease, neuropathy, foot disease and renal disease. 
This may well have been for two reasons: Firstly, because the patients did not have 
any co-morbidities, but there were a number of people who did have significant co-
morbidities which were picked up because of the medication they were on. These co-
morbidities were not listed in the referral letters. Secondly, we feel that this is one of 
those situations when a mention should be made of ‘relevant negatives’. Several co-
morbidities are much more common in people with diabetes, and these can make a 
material difference to how the patients are managed by the surgeon, the anaesthetist 
and the nursing staff.  
 
Also 11.8% of referrals had no documentation of insulin or oral hypoglycaemic 
medication usage. It is possible that these were people with diet controlled diabetes. 
The individual patient notes were not examined to see if this was the case. However, 
all patients with diabetes should be regarded as high-risk and therefore appropriate 
peri-operative measures should be taken to minimise risk and anticipate potential 
complications such as hyper or hypoglycaemia, misuse of insulin and errors 
associated with converting IV insulin infusion to regular oral hypoglycaemic 
medication [9]. Previous work has shown that patients with DM often require referral 
to critical care for post-operative management [26]. They also require input from the 
  
specialist DM team because polypharmacy and complicated insulin regimes can put 
patients with DM at risk if not appropriately monitored.  
 
Agents that are used to treat diabetes are very rarely used to treat any other 
conditions. An exception to this is metformin for polycystic ovarian syndrome but the 
numbers of people with this condition were likely to be very small. Thus when a 
diabetes drug was listed it was assumed to be because the patient had diabetes. 
 
Our data also highlight the need for increased awareness about the importance of 
DM among primary and secondary care teams. The recent decision by the UK 
National Institute for Health and Care Excellence (NICE) to ensure that a recent 
HbA1c for people with diabetes is available pre-operatively [21], means that they 
recognise that there is an onus on primary care teams and surgeons to ensure that a) 
they know who has diabetes, and b) that this information is passed on between 
stages in the patient journey, not just at the time of referral.   
 
The higher rate of referrals for patients with diabetes when compared to the 
background population is consistent with previous studies which demonstrated an 
over-representation of patients with DM undergoing surgery [20,22]. The 
phenomenon was more pronounced in referrals to vascular surgery where 24·1% of 
referrals were for patients with DM, possibly reflecting the higher cardiovascular 
disease burden these patients carry.  
 
The strength of these data are that they were collected from a very wide 
geographical area across the East of England, from 9 different hospitals. These 
included large teaching hospitals as well as much smaller district general hospitals. 
  
The data were collected based on the UK national guidelines and included data on 
referrals made to all surgical specialities, and thus should be applicable to most 
situations in the UK and further afield.  
 
The limitations of the data are that it was from only 1 week. Whist we tried to ensure 
that all the referrals were captured, and we had several mechanisms in place to 
ensure this was the case (including interrogating the electronic databases of each 
institution) there may have been some that we missed. However, we believe that this 
is unlikely to have made a material difference to our findings. It is also worth noting 
that a substantial proportion of surgical referrals resulted in conservative 
management or surgery was deemed inappropriate. For those that did go on to have 
surgery, we did not have outcome data on these individuals. However, that was not 
the intention of this study. In addition, there are conflicting data on the significance of 
poor perioperative glycaemic control and surgical outcomes. A recent systematic 
review of twenty studies including 19,514 patients with DM showed no association 
between elevated preoperative HbA1c and increased post-operative morbidity and 
mortality [27]. The authors of the study did however state that analysis was difficult 
due to the heterogeneity of the studies included. Nevertheless, UK national guidance 
recommends that primary care teams should be aiming for an HbA1c less than 
69mmol/mol where it is possible to achieve [9].  
 
These findings are not to be taken as a criticism of primary care teams. As heath 
care professions whose primary concern is the common goal of the wellbeing and 
safety of the patients under our care, this service improvement exercise was just that 
– an attempt to identify where the gaps in care lie along this initial part of the patient 
journey. The next logical stage would be to try and improve the communication gap 
  
we have identified. We are aware that many referrals are now made electronically, 
with much of the data that is recommended to be included now being so. However, 
this still relies on up to date biochemistry being done. 
 
Another reason why early identification of people with diabetes is important is 
because of data showing that it is those people with previously diagnosed diabetes 
who do better than those who have previously unidentified hyperglycaemia [28,29]. 
Thus the very knowledge that someone has diabetes, regardless of glycaemic control, 
makes a material difference to outcomes.  
 
This study is the first to examine the quality of care at the start of the patient journey. 
It is one of the many steps along the way where appropriate, and comprehensive 
communication can reduce peri-operative morbidity and mortality. The next step in 
evaluating the management of peri-operative surgical patient with DM would be the 
assessment of processes carried out in surgical outpatients, the preoperative 
assessment clinic to determine the degree of glycaemic optimisation of the patient 
with DM undergoing elective surgery. 
 
CONCLUSION 
In summary, we have shown that the quality of diabetes related information in letters 
from primary care teams for patients with diabetes referred for elective surgery in all 
specialities could be improved, with appropriate clinical information, to facilitate better 
clinical care. In addition, we have found that the proportion of patients with diabetes 
referred for surgery is almost 50% higher than would be expected if the rates were 
the same as the general population.  
 
  
Further work needs to be done to improve the peri-operative care of the patient with 
diabetes undergoing a surgical procedure. 
 
 
 
  
  
Legends for Tables and Figures 
 
Table 1. 
Minimum data set recommended for GP letter with recommendations for referral of 
patients with DM for surgery. DM – Diabetes mellitus. Taken from reference [9]. 
 
Table 2. 
Number of surgical referrals by hospital Trust 
 
Table 3. 
Number of surgical referral and proportion of referrals with DM by specialty 
 
Table 4. 
Summary of minimum data set information for the 169 patients referred with diabetes 
mellitus. *Co-morbidities include 1 or more of hypertension, ischaemic heart disease, 
neuropathy, foot disease and renal disease. +64mmol/mol (43-98mmol/mol) = 8.0% 
(6·1-11·1%). 
 
Figure 1 
The data collection tool used 
 
 
 
  
  
Table 1 
Up to date current DM care 
Duration and type of DM 
Place of usual DM care (primary or 
secondary care) 
Other co-morbidities 
Treatment 
 For DM: Oral agents/insulin 
doses and frequency 
 For other co-morbidities 
 
Specific complications of DM 
At risk foot 
Renal impairment 
Cardiac disease 
Recent values for 
Body Mass Index (BMI) 
Blood pressure 
Glycated haemoglobin (HbA1c) 
estimated Glomerular Filtration Rate 
(eGFR) 
 
 
 
 
 
 
 
 
  
  
Table 2 
Hospital Number of surgical referrals received (%) 
Addenbrooke's Hospital NHS Trust 135 (7.0) 
Bedford Hospital NHS Trust 93 (4.8) 
Hinchingbrooke Health Care NHS 
Trust  
113 (5.9) 
Luton and Dunstable University 
Hospital NHS Trust 
44 (2.3) 
Norfolk and Norwich University 
Hospitals NHS Trust 
751 (39.1) 
Queen Elizabeth Hospital Kings Lynn 
NHS Trust 
189 (9.8) 
West Suffolk NHS Foundation Trust  155 (8.1) 
Mid Essex Hospital Services NHS 
Trust  
360 (18.8) 
Peterborough City Hospital NHS 
Trust 
79 (4.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 3 
Subspecialties Number of referrals Patients with DM (%) 
Vascular surgery 54 13 (24·1%) 
General surgery  419 53 (12·6%) 
Maxillofacial surgery 9 1 (11·1%) 
Trauma and 
Orthopaedics  
459 47 (10·2%) 
Urology  195 16 (8·2%) 
Plastic surgery 126 7 (5·6%) 
Obstetrics and 
Gynaecology 
205 10 (4·9%) 
Breast surgery 84 4 (4·8%) 
Ear, Nose and Throat 353 13 (3·7%) 
Neurosurgery  1 0 (0%) 
Paediatric surgery 7 0 (0%) 
No data  7 0 (0%) 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 4 
  
Number of 
referrals with 
information 
included in 
referral letter 
about DM (%) 
Median (range) 
Type of DM 
Type 1 14 (8.3) - 
Type 2 117 (69.2) - 
Not 
Documented 
38 (22.5) - 
Place of care for 
DM 
management 
Primary Care 24 (14.2) - 
Secondary 
Care 
7 (4.1) - 
Not 
Documented 
138 (81.7) - 
DM related 
clinical 
information 
Systolic Blood 
Pressure 
53 (31.4) 
134mmHg  
(101-169mmHg) 
Body Mass 
Index 
46 (27.0) 
31.3kg/m2 (19-
45.8) 
HbA1c 13 (7.7) 
64mmol/mol (43-
98mmol/mol)+ 
eGFR 11 (6.5) 
64mL/mol (20-
90mL/mol) 
Co-morbidities* 
1 co-morbidity 44 (26.0) - 
2 co-morbidities 27 (16.0) - 
3 co-morbidities 12 (7.1) - 
4 co-morbidities 2 (1.2) - 
Not 
documented in 
referral letter 
84 (49.7) - 
Treatment Oral 
hypoglycaemics 
88 (52.1) - 
  
alone 
Insulin alone 19 (11.2) - 
Insulin and oral 
hypoglycaemics 
18 (10.7) - 
None 24 (14.2) - 
Not provided 20 (11.8) - 
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